Trial site
Latin Clinical Trial Center
- 14running trials
- 10closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Obesity10 trials
- Type 2 diabetes10 trials
- Fatty liver disease (MASLD/MASH)5 trials
- Lupus (SLE)3 trials
- High blood pressure2 trials
- Liver cirrhosis2 trials
- Osteoarthritis1 trial
- Rheumatoid arthritis1 trial
- Phase
- Phase 315 trials
- Phase 28 trials
- Phase 41 trial
- Status
- Completed9 trials
- Recruiting7 trials
- Active, not recruiting6 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company9 trials
- Amgen6 trials
- Boehringer Ingelheim3 trials
- Gilead Sciences1 trial
- Lakefront Biotherapeutics NV1 trial
- and 4 more
Running trials
Recruiting
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
Recruiting
Active, not recruiting
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity5 recruiting
- Type 2 diabetes4 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- High blood pressure1 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Completed
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Terminated
Completed
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Recruiting
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Completed
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
Site data: ClinicalTrials.govUpdated 18 Nov 2026